In Europe, lung cancer ranks third among the most common cancers, remaining the biggest killer. Since the publication of the first European Society of Radiology and European Respiratory Society joint white paper on lung cancer screening (LCS) in 2015, many new findings have been published and discussions have increased considerably. Thus, this updated expert opinion represents a narrative, non-systematic review of the evidence from LCS trials and description of the current practice of LCS as well as aspects that have not received adequate attention until now. Reaching out to the potential participants (persons at high risk), optimal communication and shared decision-making will be key starting points. Furthermore, standards for infrastructure, pathways and quality assurance are pivotal, including promoting tobacco cessation, benefits and harms, overdiagnosis, quality, minimum radiation exposure, definition of management of positive screen results and incidental findings linked to respective actions as well as cost-effectiveness. This requires a multidisciplinary team with experts from pulmonology and radiology as well as thoracic oncologists, thoracic surgeons, pathologists, family doctors, patient representatives and others. The ESR and ERS agree that Europe's health systems need to adapt to allow citizens to benefit from organised pathways, rather than unsupervised initiatives, to allow early diagnosis of lung cancer and reduce the mortality rate. Now is the time to set up and conduct demonstration programmes focusing, among other points, on methodology, standardisation, tobacco cessation, education on healthy lifestyle, cost-effectiveness and a central registry.

7th Respiratory Medicine Dept Athens Chest Hospital Sotiria Athens Greece

Center for Global Tobacco Control Department of Society Human Development and Health Harvard School of Public Health Boston MA USA

Central Pathology Laboratory Trinity College Dublin St James's Hospital Dublin Ireland

Clinic of Social and Family Medicine Faculty of Medicine University of Crete Heraklion Greece

Community Health Association Romania Bucharest Romania

Dept of Biomedical Imaging and Image guided Therapy Medical University of Vienna Vienna Austria

Dept of Diagnostic and Interventional Radiology University Hospital Heidelberg German Center of Lung Research Heidelberg Germany

Dept of Health Care of Moscow Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies Moscow Russian Federation

Dept of Pneumology Klinikum Emil von Behring Berlin Germany

Dept of Radiology Nijmegen Medical Centre Nijmegen The Netherlands

Dept of Radiology Policlinico Universitario Agostino Gemelli Rome Italy

ELF Advocacy Tipton UK

European Lung Foundation Sheffield UK

Faculté de Médecine et de Maïeutique Lyon Sud Charles Mérieux Université Claude Bernard Lyon 1 Oullins France

Holstebro Denmark

Image Sciences Institute University Medical Centre Utrecht The Netherlands

Intensive Care Unit Korgialeneion Benakeion General Hospital Athens Greece

Internal Medicine F Rabin Medical Center Petah Tikva Israel

Medical Sciences Faculty of Health Sciences University of Beira Interior Covilha Portugal

Otto Wagner Hospital Vienna Vienna Austria

Pulmonology Universitair Ziekenhuis Antwerpen Edegem Belgium

Radiology Dept Cochin Hospital APHP Paris France

Radiology University Hospital of Antwerp Edegem Belgium

Royal Brompton Hospital London UK

S E N A s r o Prague Czech Republic

Section of Radiology Dept of Medicine and Surgery University of Parma Parma Italy

Service de Pneumologie et Oncologie Thoracique Hospices Civils de Lyon CH Lyon Sud Pierre Bénite France

Thoracic Cancer Unit Rabin Medical Center Petach Tiqwa Israel

Tobacco Cessation Unit CHCB University Hospital Covilha Portugal

Citace poskytuje Crossref.org

ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer

Important steps towards a big change for lung health: a joint approach by the European Respiratory Society, the European Society of Radiology and their partners to facilitate implementation of the European Union's new recommendations on lung cancer screening